Answers are grounded in this paper and cite their sources.
We estimated the Kenyan retinoblastoma incidence, and distribution by age, sex, family history, ethnicity and province. A nationwide chart-review identified retinoblastoma cases between 1 January 2006 and 31 December 2007 (supplementary methods). We observed 206 cases in 46 Kenyan healthcare facilities, of which 58 (28%) were lost after referral, and 148 (72%) were traceable (figure 1). We excluded 16 cases, comprising 3 missing files and 13 with histology inconsistent with retinoblastoma (figure 2), leaving 132 cases. The concordance of 91% of available histological reports with the initial clinical diagnosis indicates that initial clinical diagnosis of retinoblastoma is performed adequately. Figure 1 Retinoblastoma cases observed in 2006 and 2007 (n=206). From the total number of cases clinically diagnosed as having retinoblastoma (Rb), seen over the 2-year period in 46 Kenyan healthcare facilities, we excluded cases lost after referral, with missing files or later showing histology inconsistent with Rb. This group of confirmed Rb cases was further narrowed down to the traceable population diagnosed during 2007. We added the estimated confirmed Rb cases from the untraceable study population to estimate the total number of newly diagnosed Rb cases in 2007. Figure 2 Histology of excluded cases (n=13). Histopathology reports showed 13 cases clinically reported …
No takes yet. Share an insight, caveat, or question.
Nyamori et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: